Filing identity and reporting period
The supplied filing is GX Acquisition Corp.’s unaudited Form 10-Q for the quarter ended September 30, 2019, filed November 13, 2019. It is not a Celularity Inc. filing; the text identifies GX Acquisition Corp. as a blank-check company seeking a business combination. No Celularity-specific financial or operating information is provided.
Financial results and liquidity
- Operations and revenue: GX reported no operating revenue and had not commenced business operations. It reported operating and formation costs of $202,004 for Q3 and $317,375 for the nine months ended September 30, 2019.
- Net income: $1,121,167 for Q3 and $1,755,706 for the nine-month period, primarily reflecting trust-account interest. Q3 included $1,679,863 of interest income, a $58,660 unrealized loss, and $298,032 of income tax expense; the nine-month period included $2,351,856 of interest income, a $187,932 unrealized gain, and $466,707 of income tax expense.
- Per-share result: Reported basic and diluted net loss per share was $0.01 for Q3 and $0.02 for the nine-month period. The filing allocates trust earnings to redeemable shares under its two-class method; consequently, this per-share loss differs from reported net income.
- Cash flow: Cash used in operating activities was $874,029 for the first nine months. Cash at September 30 was $1,024,811 outside the trust account. The company reported $289,504,788 of trust-account marketable securities, primarily short-term U.S. Treasury bills; $535,000 of trust interest had been withdrawn to pay income taxes.
- Capital structure and obligations: Total liabilities were $10,958,780, including a $10,812,500 deferred underwriting fee payable only if a business combination is completed. The company reported no long-term debt. Common stock subject to possible redemption was $274,806,490; stockholders’ equity was $5,000,001.
- Margins and comparison: Operating margins are not meaningful because the company had no operating revenue. The filing does not provide a directly comparable Q3 2018 quarter; its 2018 comparison covers only inception through September 30, 2018, when it reported a $545 net loss.
Business outlook, risks, and unusual items
Management intended to use substantially all trust funds toward a business combination and said it did not expect to need additional funds for ordinary operating needs, while acknowledging that higher-than-estimated search and transaction costs or substantial shareholder redemptions could require financing. No target or transaction guidance is provided. The company had until May 23, 2021 to complete a business combination; otherwise, it generally must redeem public shares and liquidate.
Public shareholders may redeem shares in connection with a business combination. The company must meet a $5,000,001 net tangible asset threshold to complete one. The sponsor’s trust-protection indemnity may not be collectible: the filing says the sponsor has not reserved funds and its ability to satisfy the obligation is uncertain. Warrants may expire worthless if no business combination is completed. Management reported effective disclosure controls and no material changes in internal control; it reported no legal proceedings and no material changes to previously disclosed risk factors.
Important facts for investors to verify
- Confirm the issuer: this is GX Acquisition Corp., not Celularity Inc.; verify that this is the intended filing.
- Verify whether a business-combination target or later transaction was announced and whether it closed before the May 23, 2021 deadline.
- Review trust-account funds, tax withdrawals, redemption activity, and the deferred underwriting fee when assessing funds available for a transaction.
- Assess the sponsor indemnity’s practical collectability and the potential dilution, financing needs, and warrant terms associated with any business combination.